Alignment Healthcare is growing revenues at 33% year-over-year with a strong analyst consensus (26% upside to target) and a favorable reward-to-risk ratio, but overall quality remains just below the minimum investment threshold — held back by near-zero operating margins and the complete absence of revenue diversification beyond government contracts; high short interest of 13% adds a binary volatility overlay to any catalyst.
Thesis pillars
- Quality Below Floor Thin Margins→Stable
- Accelerating Revenue Growth→Stable
- Cms Contract Concentration Risk→Stable
- +1 more pillar — see the Why tab for full reasoning
Pillars as of Jul 3, 2026, based on the 10-K filed Feb 27, 2026
Alignment Healthcare, Inc. (ALHC) Stock Analysis
Recovery setup · Inst Constrain edge
Healthcare · Healthcare Plans
Wait for pullback to $7.76. Weak momentum; also insider activity concern, below 200-day MA (death cross) — blocks BUY_NOW at $8.18. Engine's entry $7.76 (Default 5pct Sticky) is the shallowest technical level that clears the 2:1 A.R:R minimum. Key risks: Concentration risk — Customer: CMS contracts; V7 low-quality RISK_OFF penalty: -0.5 (Q=4.5).
Alignment Healthcare offers Medicare Advantage plans to seniors in 45 markets across California, North Carolina, Nevada, Arizona, and Texas, with 236,300 members as of December 31, 2025. Revenue comes via capitated per-member-per-month CMS payments; the company earned its 36%... Read more
Wait for pullback to $7.76. Weak momentum; also insider activity concern, below 200-day MA (death cross) — blocks BUY_NOW at $8.18. Engine's entry $7.76 (Default 5pct Sticky) is the shallowest technical level that clears the 2:1 A.R:R minimum. Key risks: Concentration risk — Customer: CMS contracts; V7 low-quality RISK_OFF penalty: -0.5 (Q=4.5). Chart setup: Death cross but MACD improving, RSI 42. Earnings today. Wait until post-earnings. Score 6.0/10, moderate confidence.
Passes 5/9 gates (favorable risk/reward ratio, no SEC red flags, news events none recent, semi cycle peak clear, materials cycle peak clear). Fails on weak momentum and clean insider activity and death cross (50MA < 200MA) and earnings proximity 0d<=7d. Suitability: speculative.
About Alignment Healthcare, Inc.
About Alignment Healthcare, Inc.
Alignment Healthcare enrolled 236,300 Medicare Advantage members across 45 markets as of December 31, 2025, having grown from approximately 13,000 at inception in 2013 at a 30% compound annual growth rate. The company operates in California (22 markets), North Carolina (16 markets), Arizona (3 markets), Nevada (2 markets), and Texas (2 markets), covering approximately 8.4 million Medicare-eligible seniors. Five-year compound revenue growth through December 31, 2025 reached 36%.
Alignment earns revenue through fixed capitated per-member-per-month (PMPM) payments from the Centers for Medicare & Medicaid Services (CMS) under Medicare Advantage contracts. Payment rates vary by county-level benchmarks, member health risk scores, and CMS Star Ratings; plans rated 4.0 Stars or higher receive benchmark increases that allow richer supplemental benefits. Approximately 100% of members were enrolled in 4.0 Star-rated plans for the 2026 rating year and 2027 payment year. Rather than relying on prior authorization and administrative cost controls common to traditional health insurers, Alignment deploys its Care Anywhere program, staffed by more than 450 full-time clinical employees — roughly 25% of its total workforce — including employed physicians, advanced practice clinicians, case managers, social workers, and behavioral health coaches. These clinicians target the 14% of members classified as "chronic," who account for 78% of institutional claims. The proprietary AVA platform ingests longitudinal data from more than 200 sources, generating prescriptive care interventions and predicting hospital admission and re-admission risk.
Show full overview
CMS annually updates Star Ratings methodology, creating a revenue threshold at the 4.0-Star boundary. In 2024, CMS removed performance outliers via the Turkey outlier deletion method, raising cut points industry-wide; the 2026 Star ratings cycle yielded only 18 five-star MA-Part D contracts, down from 57 in 2023. Alignment's CMS contracts each carry a one-year term expiring December 31 of the applicable calendar year, subject to annual renewal — meaning a single adverse Star rating action or contract termination could immediately affect any of the company's 45 markets.
See also: Healthcare · Healthcare Plans
From Alignment Healthcare, Inc.'s most recent 10-K filing, extracted June 9, 2026.
Recent developments
updated 2026-10-29Recent Developments — Alignment Healthcare, Inc.
Latest news
- NEWS Needham initiates Alignment Healthcare stock rating at Hold By Investing.com - Investing.com Nigeria — Investing.com Nigeria neutral
- NEWS What to expect from Alignment Healthcare’s (ALHC) Q3 earnings - Yahoo Finance — Yahoo Finance neutral
- NEWS What to expect from Alignment Healthcare’s (ALHC) Q3 earnings - TradingView — TradingView neutral
- NEWS Alignment Healthcare's Planned Third-Quarter Dip Meets A Stock That Has Lost Nearly Half Its Value - Finviz — Finviz negative
- NEWS Alignment Healthcare (ALHC) Expands California Access, Is The 40% Undervaluation Case Convincing? - Simply Wall Street — Simply Wall Street positive
Generated 2026-10-29T11:08:50Z.
Upcoming dated catalysts
Thesis
Key Metrics
Quality Signals
Options Flow
Concentration Risks(10-K Item 1A)
- HIGHCustomerCMS contracts10-K Item 1: 'We currently derive substantially all of our revenue from CMS contracts related to our Medicare Advantage health plans.'
- MEDIUMGeographiclimited number of U.S. states10-K Item 1A: 'Our plans are concentrated in a limited number of U.S. states and we may not be able to establish new geographic presences.'
Model-generated analysis — not investment advice. Not a registered investment advisor. Past performance does not guarantee future results. How we score · Editorial policy
Show full disclosure ▾Hide full disclosure ▴
About TrendMatrix. TrendMatrix is a publisher of general securities research and market commentary. We publish on a regular schedule. All content is the same for every subscriber in a tier — we do not provide personalized investment advice and we do not take into account any individual subscriber's financial situation, investment objectives, risk tolerance, tax situation, or holdings.
Not investment advice. TrendMatrix is not a registered investment adviser. Our content is for informational and educational purposes only. Consult your own licensed investment adviser, broker, or tax professional before making any investment decision.
Conflicts and positions. People who build TrendMatrix, or entities they control, may hold positions, long or short, in securities it covers, and may trade them at any time. Positions are not disclosed individually. Verdicts are generated by an automated model applied by the same rules to every covered stock, and are not adjusted for any position held by the people who build TrendMatrix. We do not accept payment from issuers for coverage.
No paid promotion. TrendMatrix does not accept payment from any issuer, broker, or third party in exchange for coverage of any security.
No fiduciary duty. No fiduciary, advisory, or agency relationship is created between you and TrendMatrix by reading our content or subscribing to our service.
Performance. Past performance is not indicative of future results. Performance figures reflect the published model only and do not reflect any individual subscriber's actual results.
Rating Breakdown
3 floor-breakers·1 ceiling hit
Price action weak — below key moving averages, no momentum carry. Needs a base before trend-continuation setups apply.static
Technicals below the gate floor. Component breakdown shows what dragged the score down.static
Ranks in the bottom of its industry peers on the composite signal. Better names in the same sector exist.static
Price Targets
Position Sizing
Risk Alerts
Earnings
Verdict History
Frequently Asked Questions
Wait for pullback to $7.76. Weak momentum; also insider activity concern, below 200-day MA (death cross) — blocks BUY_NOW at $8.18. Engine's entry $7.76 (Default 5pct Sticky) is the shallowest technical level that clears the 2:1 A.R:R minimum. Key risks: Concentration risk — Customer: CMS contracts; V7 low-quality RISK_OFF penalty: -0.5 (Q=4.5). Chart setup: Death cross but MACD improving, RSI 42. Earnings today. Wait until post-earnings. Target $10.71 (+30.9%), stop $7.22 (−13.3%), A.R:R 2.1:1. Score 6.0/10, moderate confidence.
Take-profit target: $10.71 (+30.9% upside). Target $10.71 (+30.9%), stop $7.22 (−13.3%), A.R:R 2.1:1. Stop-loss: $7.22.
Concentration risk — Customer: CMS contracts; V7 low-quality RISK_OFF penalty: -0.5 (Q=4.5); Leverage penalty (D/E 1.2): -0.5.
Alignment Healthcare, Inc. trades at a P/E of 43.1 (forward 12.6). TrendMatrix value score: 7.6/10. Verdict: Buy (Wait for Entry).
20 analysts cover ALHC with a consensus score of 4.3/5. Average price target: $12.
What does Alignment Healthcare, Inc. do?Alignment Healthcare offers Medicare Advantage plans to seniors in 45 markets across California, North Carolina,...
Alignment Healthcare offers Medicare Advantage plans to seniors in 45 markets across California, North Carolina, Nevada, Arizona, and Texas, with 236,300 members as of December 31, 2025. Revenue comes via capitated per-member-per-month CMS payments; the company earned its 36% five-year compound revenue growth by proactively managing member care through its proprietary AVA technology platform and in-house Care Anywhere clinical teams.